NewsLayer PulseLIVEBTC$83,049+1.66%ETH$2,458+2.58%SOL$106.81+1.97%XRP$1.34+3.08%DOGE$0.0821+3.72%ADA$0.2256+4.01%Total Cap$2.90T+1.62%24H Vol$130.2BLayer Index49 Neutral

BreakingCapital Is Repricing Crypto Around Infrastructure Trust Rather Than Narrative Heatbir saat önce

Artificial Intelligence

OpenAI, Kendi Ajanlarının Yapay Zeka Hatalarını Denetleyen Sistemi Zayıflattığını Söyledi

OpenAI, Kendi Ajanlarının Yapay Zeka Hatalarını Denetleyen Sistemi Zayıflattığını Söyledi Bloomberg.com

Bloomberg.com

Publisher

Oct 21, 2026 at 12:12 AM UTC · Updated bir saat önce · 1 dk okuma

OpenAI, Kendi Ajanlarının Yapay Zeka Hatalarını Denetleyen Sistemi Zayıflattığını Söyledi — Image via Bloomberg.com

OpenAI, Kendi Ajanlarının Yapay Zeka Hatalarını Denetleyen Sistemi Zayıflattığını Söyledi Bloomberg.com

Sourced by

Originally reported by Bloomberg.com

NewsLayer coverage based on externally reported material.

The Daily Brief

The onchain economy, before your day starts.

Curated markets, onchain insights, and key headlines — delivered every weekday morning.

Weekdays · Free · ~5 minute read

0

Applause

Was this article helpful?

Article Intelligence

Topics

Sponsored

Ad

House — Advertise on NewsLayer

NewsLayerLearn more

NewsLayer Premium

Unlock deeper intelligence.

Ad-free reading, exclusive research, and real-time onchain insights.

Keep Reading

İlgili Haberler

SDSU students call on university system to cancel contract with OpenAI

AZTECS SEEK OPENAI EXIT

SDSU students call on university system to cancel contract with OpenAI

SDSU students call on university system to cancel contract with OpenAI KPBS

2 saat önce

OpenAI acquires Orchestra Bio to bring AI agents into drug development

OpenAI acquires Orchestra Bio to bring AI agents into drug development

OpenAI has acquired Orchestra Bio, according to a SiliconANGLE report. The deal is aimed at bringing AI agents into drug development workflows.

2 saat önce

OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work

OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work

OpenAI has acquired Orchestra Bio and plans to integrate its drug-development AI agents into Rosalind, OpenAI’s life sciences suite. The move is aimed at automating parts of pharmaceutical development and reducing the lengthy timeline for bringing medicines to patients.

4 saat önce